Allscripts (MDRX) Tops Q3 EPS by 1c

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $402.1 million versus the consensus estimate of $421.79 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• USA Rare Earth names Thras Moraitis as new CEO
• Jefferies Starts Macmahon Holdings Ltd (MAH:AU) at Hold